Teachers Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Teachers Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$67.6M	Buy	4,308,339 +714,400	+20%	+$12.6M	0.08%	252
2018 Q4	$55.4M	Sell	3,593,939 -2,547,386	-41%	-$52.2M	0.08%	261
2018 Q3	$132M	Sell	6,141,325 -312,449	-5%	-$7.25M	0.16%	127
2018 Q2	$157M	Buy	6,453,774 +678,982	+12%	+$13.8M	0.2%	101
2018 Q1	$98.7M	Buy	5,774,792 +2,553,387	+79%	+$49.9M	0.13%	169
2017 Q4	$61M	Buy	3,221,405 +1,286,637	+67%	+$19.4M	0.08%	302
2017 Q3	$34.1M	Buy	1,934,768 +1,251,854	+183%	+$28.2M	0.05%	437
2017 Q2	$22.7M	Buy	682,914 +40,600	+6%	+$1.26M	0.03%	601
2017 Q1	$20.6M	Buy	642,314 +36,900	+6%	+$1.26M	0.03%	647
2016 Q4	$21.9M	Buy	+605,414	New	+$24.2M	0.03%	585
2016 Q3	–	Sell	-341,422	Closed	-$17.1M	–	3095
2016 Q2	$17.1M	Sell	341,422 -273,487	-44%	-$14.6M	0.03%	624
2016 Q1	$32.9M	Buy	614,909 +397,583	+183%	+$23.3M	0.06%	397
2015 Q4	$14.3M	Buy	217,326 +135,910	+167%	+$8.4M	0.03%	680
2015 Q3	$4.6M	Buy	+81,416	New	+$5.28M	0.01%	1153
2013 Q4	–	Sell	-473,062	Closed	-$17.9M	–	3094
2013 Q3	$17.9M	Sell	473,062 -276,447	-37%	-$10.8M	0.04%	543
2013 Q2	$29.4M	Buy	+749,509	New	+$29.2M	0.08%	322

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Teachers Advisors's TEVA Position: Q1 2019 in Review

Teachers Advisors increased its Teva Pharmaceuticals (TEVA) stake by 20% in Q1 2019, buying an estimated $12.6M and bringing the position to 4,308,339 shares worth $67.6M. The position accounts for 0.08% of the portfolio, ranked #252.

Teachers Advisors first reported a position in TEVA in Q2 2013 and has held it in 16 quarters since. The position peaked at $157M in Q2 2018. 521 funds tracked by Wall St. Rank hold TEVA as of Q1 2019.

Teachers Advisors held 4,308,339 shares of Teva Pharmaceuticals worth $67.6M as of Q1 2019.
Teachers Advisors bought 714,400 Teva Pharmaceuticals shares in Q1 2019, an estimated $12.6M.
Teva Pharmaceuticals made up 0.08% of Teachers Advisors's portfolio in Q1 2019, its #252 holding.
Teachers Advisors first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 16 quarters since.
Teachers Advisors's Teva Pharmaceuticals position peaked at $157M in Q2 2018.
521 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.